alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Overseas Private Investment Corporation

                    OPIC's Sunshine Act notice of its Annual Public Hearing meeting was published in the                     **Federal Register**                     (Volume 73, Number 10, Page 2558) on January 15, 2008. No requests were received to provide testimony or submit written statements for the record; therefore, OPIC's annual public hearing scheduled for 2 p.m. on January 29, 2008 has been cancelled.                

*Contact Person for Information:*                     Information on the hearing cancellation may be obtained from Connie M. Downs at (202) 336-8438, via facsimile at (202) 218-0136, or via e-mail at                     *Connie.Downs@opic.gov.*

Dated: January 24, 2008.

Connie M. Downs,

OPIC Corporate Secretary.

[FR Doc. 08-372  Filed 1-24-08; 12:10 pm]

BILLING CODE 3210-01-M
AGENDA 

Advisory Board on Radiation and Worker Health 

Meeting of the 

Metals and Controls Corp. (M&C) Working Group (WG) 

March 18, 2021 

10:30 a.m. (Eastern Daylight Time) 

Videoconference: 

Join ZoomGov Meeting 

https://cdc.zoomgov.com/j/16067633819?pwd=RUdiYXlZZHFKanpJOHZrcGJIbTlaZz09 

Meeting ID: 160 6763 3819 

Passcode: ABRWH#01 

Teleconference: 

Phone: (646) 828-7666 

Meeting ID: 160 6763 3819 

Participants ID: # 

Meeting Password: 98685439 

Welcome and roll-call/introductions 

1. DCAS follow-up to the M&C WG and WG discussion regarding: 

a. fires and explosions 

b. drain line operations during the residual period, and sample data from one pipe in 

the west end of Building 10 that was one million dpm/100 cm2 

c. HFIR alpha contamination surveys 

d. consolidation of dose models into a single document 

e. the use of mound data, including a response to M&C WG concerns that 

this site has many unique circumstances that were not present at the 

surrogate site and reassessment of if it meets surrogate criteria. 

2. Petitioners comments (optional to petitioner) 

3. SC&A review of NIOSH’s final approach for the one-to-one ratio NIOSH did using 

building 10 subsurface real data. 

4. DCAS/SC&A/WG review and discussion of the current model of ingestion of radioactive 

materials 

5. DCAS/SC&A/WG discussion of disturbance of the burial ground prior to 1992 and 

consideration of the uses and impact of 1992 CPS burial ground data on the NIOSH 

Exposure Model. 

6. WG discussion of path forward 

Adjourn
Exhibit 32.2

                    CERTIFICATION OF CHIEF FINANCIAL OFFICER
                       PURSUANT TO 18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                 SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In  connection  with the  Quarterly  Report of HQ  Global  Education  Inc.  (the
"Company")  on Form 10-Q for the period  ending  February 28, 2010 as filed with
the Securities  and Exchange  Commission on the date hereof (the  "Report"),  I,
Yunjie Fang,  Chief Financial  Officer of the Company,  certify,  pursuant to 18
U.S.C. ss.1350, as adopted pursuant to ss.906 of the Sarbanes-Oxley Act of 2002,
that:

     (1)  The Report fully  complies with the  requirements  of section 13(a) or
          15(d) of the Securities Exchange Act of 1934; and

     (2)  The  information  contained  in the  Report  fairly  presents,  in all
          material respects, the financial condition and result of operations of
          the Company.

IN WITNESS  WHEREOF,  the undersigned has executed this  certification as of the
14th day of April, 2010.


By: /s/ Yunjie Fang
  ---------------------------------
  Yunjie Fang
  Chief Financial Officer
IN THE UNITED STATES DISTRICT COURT

NORTHERN DISTRICT OF FLORIDA

PANAMA CITY DIVISION

ANTHONY BRYAN McDANIEL,

Plaintiff,

vs. CASE NO. 5:10cv205/RS-CJK

CITY OF PORT ST. JOE; JOE

NUGENT, individually and in his official 

capacity as Sheriff of Gulf County, Florida;

TROY SIMMONS; CHRIS SHEARER;

LARRY HIGHTOWER; JAKE RICHARDS;

RICKY TOLBERT; BOBBY PLAIR;

JEROME WILLIAMS; and JAMES JENSEN,

Defendants.

_________________________________________/

ORDER OF DISMISSAL

Before me is the Mediation Report (Doc. 28). Pursuant to Local Rule 16.2(D), it

is ordered:

1. This case is dismissed from the active docket of the court.

2. In the event that the settlement is not consummated, the court reserves

jurisdiction, upon motion filed by any party within sixty days of the date of this Order, to

amend or vacate and set aside this Order and reinstate the case.

3. The clerk is directed to close the file of this case for administrative

purposes, and upon the expiration of sixty days without activity, the clerk is directed to

close the case in its entirety for all purposes.
ORDERED on March 17, 2011. 

/S/ Richard Smoak 

RICHARD SMOAK

UNITED STATES DISTRICT JUDGE
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### Food and Drug Administration

          - [FDA No. 225-07-3002]

# AGENCY:

Food and Drug Administration, HHS.

# ACTION:

Notice.

# SUMMARY:

The Food and Drug Administration (FDA) is providing notice of a memorandum of understanding (MOU) between the Walter Reed Army Institute of Research, FDA, and the F. Edward Herbert School of Medicine of the Uniformed Services University of the Health Sciences. This MOU identifies the terms of collaboration between the three Federal entities in the coordination of the established Clinical Pharmacology Fellowship Training Program. Specifically, this collaboration provides for active duty Army, Air Force, Navy, and Public Health Service Medical Corps officers in the fellowship program to arrange a 2 to 4 month internship within FDA's Center for Drug Evaluation and Research (CDER) through CDER's Office of Clinical Pharmacology. 

# DATES:

The agreement became effective January 8, 2008.

# FOR FURTHER INFORMATION CONTACT:

Shiew Mei Huang, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 21, Silver Spring, MD 20993, 301-796-1541.

# SUPPLEMENTARY INFORMATION:

                    In accordance with 21 CFR 20.108(c), which states that all written agreements and MOUs between FDA and others shall be published in the                     **Federal Register**                    , the agency is publishing notice of this MOU.                 

Dated: February 8, 2008.

Jeffrey Shuren,

Assistant Commissioner for Policy.

      ( print page 9128)          ( print page 9129)          ( print page 9130)          ( print page 9131)          ( print page 9132)    

BILLING CODE 4160-01-S

[FR Doc. 08-685 Filed 2-15-08; 8:45 am]

BILLING CODE 4160-01-C
UNPUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT No. 99-6928

UNITED STATES OF AMERICA, Plaintiff - Appellee, versus MICHAEL CHARLES ANITON, Defendant - Appellant.Appeal from the United States District Court for the Middle District of North Carolina, at Durham. N. Carlton Tilley, Jr., Chief District Judge. (CR-93-157, CA-97-576-1) Submitted: November 4, 1999 Decided: November 9, 1999 Before NIEMEYER, MICHAEL, and KING, Circuit Judges. Dismissed by unpublished per curiam opinion. Michael Charles Aniton, Appellant Pro Se. Sandra Jane Hairston, Assistant United States Attorney, Greensboro, North Carolina, for Appellee. Unpublished opinions are not binding precedent in this circuit. See Local Rule 36(c).2 PER CURIAM: Michael Charles Aniton seeks to appeal the district court’s order dismissing his motion filed under 28 U.S.C.A. § 2255 (WestSupp. 1999). Aniton’s case was referred to a magistrate judge pursuant to 28 U.S.C. § 636(b)(1)(B) (1994). The magistrate judge recommended that relief be denied and advised Aniton that failureto file timely objections to this recommendation could waive appellate review of a district court order based upon the recommendation. Despite this warning, Aniton failed to object to the magistrate judge’s recommendation. The timely filing of objections to a magistrate judge’s recommendation is necessary to preserve appellate review of the substance of that recommendation when the parties have been warned that failure to object will waive appellate review. See Wright v. Collins , 766 F.2d 841, 845-46 (4th Cir. 1985); see also Thomas v. Arn , 474 U.S. 140 (1985). Aniton has waived appellate review by failing to file objections after receiving proper notice. We accordingly deny a certificate of appealability and dismiss the appeal. We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

DISMISSED
Exhibit 32.1

















CERTIFICATION PURSUANT TO


18 U.S.C. SECTION 1350,


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002








In connection with the Amended Quarterly Report of Net Savings Link, Inc., (the “Company”) on Form 10-Q/A-1 for the period ended February 28, 2014 as filed with the Securities and Exchange Commission on the date hereof (the “report”), I, David Saltrelli, Chief Executive Officer and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:





(1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and





(2)
The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company.





Dated this 22nd day of April, 2014.








DAVID SALTRELLIDavid SaltrelliChief Executive Officer and Chief Financial Officer
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The undersigned officer of Excel Global, Inc. (the "Company"), hereby
certifies, to such officer's knowledge, that the Company's Quarterly
Report on Form 10-Q for the three months ended March 31, 2008 (the
"Report") fully complies with the requirements of Section 13(a) of the
Securities Exchange Act of 1934 and that the information contained in
the Report fairly presents, in all material respects, the financial
condition and results of operations of the Company.

                                 /s/ Betty Soumekh
                                 ----------------------
                                 Betty Soumekh
                                 Chief Executive Officer
                                 Chief Financial Officer

May 20, 2008
[Federal Register Volume 73, Number 27 (Friday, February 8, 2008)]
[Notices]
[Page 7592]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 08-561]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production act of 1993--Interchangeable Virtual Instruments Foundation, 
Inc.

    A notice is hereby given that, on December 21, 2007, pursuant to 
Section 6(a) of the National Cooperative Research and Production act of 
1993, 15 U.S.C. 4301 et seq. (``the Act''), Interchangeable Virtual 
Instruments Foundation, Inc. has filed written notifications 
simultaneously with the Attorney General and the Federal Trade 
Commission disclosing changes in its membership. The notifications were 
filed for the purpose of extending the Act's provisions limiting the 
recovery of antitrust plaintiffs to actual damages under specified 
circumstances. Specifically, Santa Barbara Infrared, Santa Barbara, CA 
has withdrawn as a party to this venture.
    No other changes have been made in either the membership or planned 
activity of ther group research project. Membership in this group 
research project remains open, and Interchangeable Virtual Instruments 
Foundation, Inc. intends to file additional written notifications 
disclosing all ahcanges in membership.
    On May 29, 2001, Interchangeable Virtual Instruments Foundation, 
Inc. filed its original notification pursuant to Section 6(a) of the 
Act. The Department of Justice published a notice in the Federal 
Register pursuant to Section 6(b) of the Act on July 30, 2001 (66 FR 
39336).
    The last notification was filed with the Department on October 10, 
2007. A notice was published in the Federal Register pursuant to 
Section 6(b) of the Act on November 7, 2007 (72 FR 6265).

Patricia A. Brink,
Deputy Director of Operations, Antitrust Division.
[FR Doc. 08-561 Filed 2-7-08; 8:45 am]
BILLING CODE 4410-11-M
Exhibit 21.1


                                  SUBSIDIARIES

<TABLE>
<CAPTION>
                                                                    Name Under Which
Subsidiary                            State of Incorporation    Subsidiary Does Business
----------                            ----------------------    ------------------------
<S>                                        <C>                       <C>
Hall GMC, Inc.                             North Dakota              Corporate Name
     (85% owned)

Hall Truck Center, Inc.                    North Dakota              Corporate Name
     (85% owned)

Minnesota Valley Irrigation, Inc.            Minnesota               Corporate Name
     (100% owned)                                                      (inactive)

RDO Financial Services Co.                 North Dakota              Corporate Name
     (100% owned)

RDO Material Handling Co.                    Minnesota               Corporate Name
     (100% owned)

RDO Rental Co.                               Minnesota               Corporate Name
     (80% owned)

RDO Truck Center Co.                       North Dakota              Corporate Name
     (100% owned)

Salinas Equipment Distributors, Inc.        California               Corporate Name
     (89% owned)
</TABLE>
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 15-1884

TOYRI T. BRANDON,

Petitioner - Appellant,

v.

NATIONAL CREDIT UNION ASSOCIATION; NATIONAL CREDIT UNION 

ADMINISTRATION BOARD; DEBBIE MATZ, Chairwoman, NCUA Board,

Respondents - Appellees.

Appeal from the United States District Court for the Eastern 

District of Virginia, at Alexandria. T. S. Ellis, III, Senior 

District Judge. (1:14-cv-01461-TSE-JFA)

Submitted: December 21, 2015 Decided: January 28, 2016

Before WILKINSON, MOTZ, and FLOYD, Circuit Judges.

Dismissed by unpublished per curiam opinion.

Toyri T. Brandon, Appellant Pro Se. Antonia Marie Konkoly, 

OFFICE OF THE UNITED STATES ATTORNEY, Lauren Anne Wetzler, 

Assistant United States Attorney, Alexandria, Virginia, for 

Appellees. 

Unpublished opinions are not binding precedent in this circuit.
2

PER CURIAM:

Toyri T. Brandon appeals the district court’s order 

granting the Defendants’ motion for summary judgment.∗ We have 

reviewed the record and find no reversible error. Accordingly, 

we deny leave to proceed in forma pauperis and dismiss the 

appeal for the reasons stated by the district court. Brandon v. 

Nat’l Credit Union Ass’n, No. 1:14-cv-01461-TSE-JFA (E.D. Va. 

July 13, 2015). We dispense with oral argument because the 

facts and legal contentions are adequately presented in the 

materials before the court and argument would not aid the 

decisional process. 

DISMISSED

 ∗ We conclude that, by failing to identify any of the 

deposits she contends should have been included in the 

reconstruction, Brandon waived appellate review of her claim 

concerning the Defendants’ reconstruction of her deposit 

history. See 4th Cir. R. 34(b) (directing appellants to present

“specific issues and supporting facts and arguments” in informal 

brief); see, e.g., Eriline Co. S.A. v. Johnson, 440 F.3d 648, 

653 n.7 (4th Cir. 2006) (noting single conclusory remark 

regarding error “is insufficient to raise on appeal any meritsbased challenge to the district court’s ruling”); Edwards v. 

City of Goldsboro, 178 F.3d 231, 241 n.6 (4th Cir. 1999) 

(“Failure to comply with the specific dictates of [Federal Rule 

of Appellate Procedure 28] with respect to a particular claim 

triggers abandonment of that claim on appeal.”).
IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

No. 11-40486

Summary Calendar

UNITED STATES OF AMERICA,

Plaintiff-Appellee

v.

LUIS ANGEL CIBRIAN-GONZALEZ,

Defendant-Appellant

Appeal from the United States District Court

for the Southern District of Texas

USDC No. 2:09-CR-883-1

Before KING, JOLLY, and GRAVES, Circuit Judges.

PER CURIAM:*

The attorney appointed to represent Luis Angel Cibrian-Gonzalez has

moved for leave to withdraw and has filed a brief in accordance with Anders v.

California, 386 U.S. 738 (1967), and United States v. Flores, 632 F.3d 229 (5th

Cir. 2011). Cibrian-Gonzalez has not filed a response. We have reviewed

counsel’s brief and the relevant portions of the record reflected therein. We

concur with counsel’s assessment that the appeal presents no nonfrivolous issue

for appellate review. Accordingly, counsel’s motion for leave to withdraw is

GRANTED, counsel is excused from further responsibilities herein, and the

APPEAL IS DISMISSED. See 5TH CIR. R. 42.2.

United States Court of Appeals

Fifth Circuit

F I L E D

November 30, 2011

Lyle W. Cayce

Clerk

Pursuant to 5TH CIR. R. 47.5, the court has determined that this opinion should not *

be published and is not precedent except under the limited circumstances set forth in 5TH CIR.

R. 47.5.4.

Case: 11-40486 Document: 00511680380 Page: 1 Date Filed: 11/30/2011
[Federal Register Volume 73, Number 33 (Tuesday, February 19, 2008)]
[Notices]
[Pages 9122-9126]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 08-686]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[FDA No. 225-08-8002]


Memorandum of Understanding Between the Division of Select Agents 
and Toxins Center for Disease Control and Prevention and the Food and 
Drug Administration

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is providing notice of 
a memorandum of understanding (MOU) between FDA and the Division of 
Select Agents and Toxins (DSAT) of the Centers for Disease Control and 
Prevention (CDC). The purpose of this MOU is to establish a procedure 
to allow CDC/DSAT to confirm that FDA has accepted or approved, under 
the authority of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 
301 et seq), an Investigational New Drug application (IND), a request 
to establish an Investigational New Animal Drug file (INAD), or an 
Investigational Device Exemption application (IDE) for a clinical trial 
involving the use of an investigational product that is, bears, or 
contains a select agent or toxin.

DATES: The agreement became effective January 25, 2008.

FOR FURTHER INFORMATION CONTACT: Jarilyn Dupont, Director of Regulatory 
Policy, Office of Policy and Planning (HF-11), Food and Drug 
Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-5906.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 20.108(c), which 
states that all written agreements and MOUs between FDA and others 
shall be published in the Federal Register, the agency is publishing 
notice of this MOU.

    Dated: February 8, 2008.
Jeffrey Shuren,
Assistant Commissioner for Policy.
BILLING CODE 4160-01-S

[[Page 9123]]

[GRAPHIC] [TIFF OMITTED] TN19FE08.000


[[Page 9124]]


[GRAPHIC] [TIFF OMITTED] TN19FE08.001


[[Page 9125]]


[GRAPHIC] [TIFF OMITTED] TN19FE08.002


[[Page 9126]]


[GRAPHIC] [TIFF OMITTED] TN19FE08.003

[FR Doc. 08-686 Filed 2-15-08; 8:45 am]
BILLING CODE 4160-01-C?>
Exhibit 32.1  CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002  In connection with the Quarterly Report of Adtomize Inc. (the Company) on Form 10-Q for the period ended December 31, 2010 as filed with the Securities and Exchange Commission on the date hereof (the Report), the undersigned, in the capacities and on the dates indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:  1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and  2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.   Date:   February 2, 2011   /s/ Barry Wattenberg --------------------------------- Barry Wattenberg, Principal Executive Officer and Principal Accounting Officer
Exhibit 32.2
 CERTIFICATION OF PERIODIC FINANCIAL REPORTS PURSUANT TO 18 U.S.C. §1350
  1.
    
    The periodic report containing financial statements to which this certificate is an exhibit
fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act
of 1934.
 2.
    
    The information contained in the periodic report to which this certificate is an exhibit
fairly presents, in all material respects, the financial condition and results of operations
of the Company.
   By:
    /s/ FRANCIS K. CHANFrancis K. ChanExecutive Vice President and
Chief Financial Officer